Task: Answer the MCQ question.
Question: Which drug has a -12.577% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CSc1ccccc1C(=O)N1CCN(c2cccc(Cl)c2)CC1
b: C=CCN(CC=C)C(=S)NC(=O)c1ccc(C)c(Br)c1
Answer: b. C=CCN(CC=C)C(=S)NC(=O)c1ccc(C)c(Br)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCN(CC=C)C(=S)NC(=O)c1ccc(C)c(Br)c1
C=CCN(CC=C)C(=S)NC(=O)c1ccc(C)c(Br)c1
N-[bis(prop-2-enyl)carbamothioyl]-3-bromo-4-methylbenzamide